SCHEMBL31661185

SCHEMBL31661185

CC(C)(C)OC(=O)N1CCN(c2ccc3c(c2)OCC32CCC(=O)NC2=O)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 6/20 0.46
DDB1 Q16531 5/20 0.46
PDK2 Q15119 1/20 0.44
MAPT P10636 2/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TSHR P16473 1/20 0.38
GPR119 Q8TDV5 3/20 0.38
NAMPT P43490 1/20 0.38
WNT3A P56704 1/20 0.38
MMP2 P08253 1/20 0.38
MMP13 P45452 1/20 0.38
MMP14 P50281 1/20 0.38
ADAMTS5 Q9UNA0 1/20 0.38
ALK Q9UM73 3/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31661163 0.85 CRBN (0.38) CRBNDDB1PDK2MAPTALDH1A1
SCHEMBL31661166 0.85 CRBN (0.38) CRBNDDB1PDK2MAPTALDH1A1
SCHEMBL31661181 0.84 DDB1 (0.49) CRBNDDB1MAPTGPR119NAMPT
SCHEMBL31661180 0.81 CRBN (0.46) CRBNDDB1PDK2MAPTALDH1A1
SCHEMBL31661179 0.80 CRBN (0.41) CRBNDDB1PDK2MAPTALDH1A1
SCHEMBL31661169 0.79 MAPKAPK2 (0.38) CRBNDDB1PDK2MAPTCYP2C19
SCHEMBL31701643 0.76 PDK2 (0.54) CRBNDDB1PDK2MAPTALDH1A1
SCHEMBL27371048 0.75 PDK2 (0.49) CRBNDDB1PDK2MAPTALDH1A1
SCHEMBL31543806 0.75 CRBN (0.42) CRBNDDB1GPR119
SCHEMBL30955807 0.74 DDB1 (0.54) CRBNDDB1PDK2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151602-A1 HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4 BRISTOL-MYERS SQUIBB COMPANY (US) 2025-07-17 WO disclosed